Revilla, Hepolito A.

HRN: 26-68-04  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2026
CEFTRIAXONE 1G (VIAL)
03/07/2026
03/14/2026
IV
2g
OD
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: